1,12-Dodecanediol, 2,11-dimethyl-2,11-dipropyl-

Suppliers

Names

[ CAS No. ]:
85018-69-5

[ Name ]:
1,12-Dodecanediol, 2,11-dimethyl-2,11-dipropyl-

[Synonym ]:
2,11-Dimethyl-2,11-dipropyl-1,12-dodecanediol
1,12-Dodecanediol,2,11-dimethyl-2,11-dipropyl

Chemical & Physical Properties

[ Density]:
0.889g/cm3

[ Boiling Point ]:
414.7ºC at 760 mmHg

[ Molecular Formula ]:
C20H42O2

[ Molecular Weight ]:
314.54600

[ Flash Point ]:
172.2ºC

[ Exact Mass ]:
314.31800

[ PSA ]:
40.46000

[ LogP ]:
5.70460

[ Index of Refraction ]:
1.464

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
JR2435710
CHEMICAL NAME :
1,12-Dodecanediol, 2,11-dimethyl-2,11-dipropyl-
CAS REGISTRY NUMBER :
85018-69-5
LAST UPDATED :
199603
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C20-H42-O2
MOLECULAR WEIGHT :
314.62

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0064286
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0064286

Related Compounds

  • 1,12-Dodecanediol, 2,11-diethyl-2,11-dimethyl-
  • [2,11-dimethyl-2-propyl-11-(pyridine-3-carbonyloxymethyl)tetradecyl] p yridine-3-carboxylate
  • Dodecanedioic acid, 2,11-dimethyl-2,11-dipropyl-
  • 2,11-dibutyl-2,11-dimethyl-dodecane-1,12-diol
  • 4,4,5,5,6,6,7,7,8,8,9,9-dodecafluoro-2,11-diiodododecane-1,12-diol
  • 1,12-dibromododecane-2,11-dione
  • 1-(3-bromophenyl)-N-(2-(3-(furan-2-yl)-6-oxopyridazin-1(6H)-yl)ethyl)-5-oxopyrrolidine-3-carboxamide
  • 4-((1H-imidazol-1-yl)methyl)-N-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)benzamide
  • 4-((1H-imidazol-1-yl)methyl)-N-(2-(4-fluorophenoxy)ethyl)benzamide
  • N-(2-(3-(furan-2-yl)-6-oxopyridazin-1(6H)-yl)ethyl)-2-phenyl-2H-1,2,3-triazole-4-carboxamide
  • N-(3-(tert-butyl)isoxazol-5-yl)-1-(thiophen-2-yl)cyclopentanecarboxamide
  • N-(benzo[c][1,2,5]thiadiazol-4-yl)-2-(benzo[d]isoxazol-3-yl)acetamide
  • 2-(benzo[d]isoxazol-3-yl)-N-(2-((4-methyl-4H-1,2,4-triazol-3-yl)thio)ethyl)acetamide
  • N-(3-(tert-butyl)isoxazol-5-yl)-4-phenyltetrahydro-2H-pyran-4-carboxamide
  • 2-(benzo[d]oxazol-2-ylthio)-N-(2-(3-(furan-2-yl)-6-oxopyridazin-1(6H)-yl)ethyl)acetamide
  • 2-phenyl-N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-1,3-thiazole-4-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.